The presence of several pulmonary hypertension mechanisms (PE, hypoxic vasoconstriction, pulmonary microthrombi, ACE2 dysregulation, and cytokine storm) inducing right ventricular dysfunction suggests the possibility to obtain a CTPA before clinical decision-making in this population [34]. Here, ACE2 is linked to pulmonary arterial hypertension.